In a study comparing expandable and static LLIF devices, at 2-year follow-up, researchers observed no implant subsidence in patients treated with expandable devices, with 16% subsidence in levels treated with static spacers.
FDA performed an inspection of Zimmer Biomet's Warsaw North Campus manufacturing facility in April 2018, and issued a Form 483 with 11 inspectional observations.Â
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more